cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study. - Dehnen D; Neuberger E; In der Schmitten J; Giagkou E; Simon P; Botzenhardt S (BMJ open, 2022)